Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection.
Sakurai
Y
Y
Department of Thoracic Surgery, Kansai Medical University, Osaka, Japan.
Kagawa
K
K
Kato
Y
Y
Otani
H
H
Nonoyama
A
A
D000179:Acrylates / Q000627:therapeutic use*; D000818:Animals; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D008689:Methacrylates / Q000627:therapeutic use*; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D016042:Transplantation, Heterotopic
D000179:Acrylates; D003524:Cyclosporins; D008689:Methacrylates; D013930:Thromboxane-A Synthase; C034364:ozagrel